Medigen Biotechnology Corp. (TPEX:3176)

Medigen Biotechnology Revenue

Medigen Biotechnology had revenue of 395.68M TWD in the quarter ending September 30, 2025, a decrease of -9.38%. This brings the company's revenue in the last twelve months to 1.59B, up 12.27% year-over-year. In the year 2024, Medigen Biotechnology had annual revenue of 1.37B with 18.57% growth.

• Revenue (ttm): 1.59B
• Revenue Growth: +12.27%
• P/S Ratio: 2.73
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 4.33B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.37B	214.98M	18.57%
Dec 31, 2023	1.16B	101.77M	9.64%
Dec 31, 2022	1.06B	-2.87B	-73.08%
Dec 31, 2021	3.92B	3.31B	537.17%
Dec 31, 2020	615.54M	63.20M	11.44%